Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of Virology
|
March 1, 1992
The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm
P Krajcsi, A E Tollefson, C W Anderson, et al.
Haematologia
|
January 1, 1986
Alterations in the number of glucocorticoid receptors of circulating lymphocytes in sepsis
A Krasznai, P Arányi, T Fehér, et al.
Current Drug Metabolism
|
May 16, 2009
Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs
A Lespine, J Dupuy, M Alvinerie, et al.
Journal of Virology
|
January 1, 1995
The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane
A R Stewart, A E Tollefson, P Krajcsi, et al.
International Journal of Cancer
|
August 14, 1999
Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrosobenzamide
R Mihalik, P Bauer, I Peták, et al.
Journal of Virology
|
February 1, 1990
A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus
A E Tollefson, P Krajcsi, S P Yei, et al.
Virology
|
March 1, 1990
A 14,500 MW protein is coded by region E3 of group C human adenoviruses
A E Tollefson, P Krajcsi, M H Pursley, et al.
Current Medicinal Chemistry
|
December 8, 2004
Recent advances in chemical genomics
F Darvas, G Dormán, P Krajcsi, et al.
Journal of Virology
|
April 1, 1997
Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes
T Dimitrov, P Krajcsi, T W Hermiston, et al.
Journal of Virology
|
March 10, 2001
Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy
K Doronin, M Kuppuswamy, K Toth, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of Virology
|
March 1, 1992
The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm
P Krajcsi, A E Tollefson, C W Anderson, et al.
Haematologia
|
January 1, 1986
Alterations in the number of glucocorticoid receptors of circulating lymphocytes in sepsis
A Krasznai, P Arányi, T Fehér, et al.
Current Drug Metabolism
|
May 16, 2009
Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs
A Lespine, J Dupuy, M Alvinerie, et al.
Journal of Virology
|
January 1, 1995
The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane
A R Stewart, A E Tollefson, P Krajcsi, et al.
International Journal of Cancer
|
August 14, 1999
Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrosobenzamide
R Mihalik, P Bauer, I Peták, et al.
Journal of Virology
|
February 1, 1990
A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus
A E Tollefson, P Krajcsi, S P Yei, et al.
Virology
|
March 1, 1990
A 14,500 MW protein is coded by region E3 of group C human adenoviruses
A E Tollefson, P Krajcsi, M H Pursley, et al.
Current Medicinal Chemistry
|
December 8, 2004
Recent advances in chemical genomics
F Darvas, G Dormán, P Krajcsi, et al.
Journal of Virology
|
April 1, 1997
Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes
T Dimitrov, P Krajcsi, T W Hermiston, et al.
Journal of Virology
|
March 10, 2001
Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy
K Doronin, M Kuppuswamy, K Toth, et al.
Page
of 3